| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Research and development expenses | |||||||||
| General and administrative expenses | |||||||||
| Impairment loss | |||||||||
| Operating loss | |||||||||
| Change in fair value of warrants | |||||||||
| Finance expenses | |||||||||
| Finance income | |||||||||
| Finance income, net | |||||||||
| Loss for the year | |||||||||
| Items that will be transferred to profit or loss: | |||||||||
| Loss (profit) from cash flow hedges | — | ||||||||
| Total comprehensive loss for the year | |||||||||
| Loss attributable to: | |||||||||
| Owners of the Company | |||||||||
| Non-controlling interests | |||||||||
| Loss for the year | |||||||||
| Total comprehensive loss attributable to: | |||||||||
| Owners of the Company | |||||||||
| Non-controlling interests | |||||||||
| Total comprehensive loss for the year | |||||||||
| Loss per share information | |||||||||
| Basic loss per Share – USD (in Dollars per share) | |||||||||
| Diluted loss per Share – USD (in Dollars per share) |